1.
Current progress in immunotherapy for pancreatic cancer
by Foley, Kelly
Cancer letters, 2015, Vol.381 (1), p.244-251
2.
Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma
by Qu, Kai
Cancer letters, 2012, Vol.331 (1), p.105-114
3.
Next-generation sequencing in the clinic: Promises and challenges
by Xuan, Jiekun
Cancer letters, 2012, Vol.340 (2), p.284-295
5.
Current Status of Biomarker and Targeted Nanoparticle Development: The Precision Oncology Approach for Pancreatic Cancer Therapy
by Zhu, Lei
Cancer letters, 2016, Vol.388, p.139-148
6.
The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance
by Zhao, Lei
Cancer letters, 2014, Vol.356 (2), p.339-346
7.
tRNA-derived small non-coding RNAs in human disease
by Zhu, Lei
Cancer letters, 2018-04-10, Vol.419, p.1-7
8.
SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance
by Wang, Tao
Cancer letters, 2018-08-28, Vol.430, p.11-24
9.
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth
by Zhang, Yijian
Cancer letters, 2016, Vol.375 (1), p.179-189
10.
Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition
by Ju, Rui
Cancer letters, 2015, Vol.370 (2), p.232-241
11.
Isolation and characterization of cancer stem like cells in human glioblastoma cell lines
by Qiang, Lei
Cancer letters, 2009, Vol.279 (1), p.13-21
12.
PD-1/PD-L1 and immunotherapy for pancreatic cancer
by Feng, Mengyu
Cancer letters, 2017-10-28, Vol.407, p.57-65
13.
Long noncoding RNAs: Novel insights into hepatocelluar carcinoma
by He, Yong
Cancer letters, 2013, Vol.344 (1), p.20-27
14.
MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a
by Zhou, Jiaojiao
Cancer letters, 2014, Vol.356 (2), p.669-675
15.
InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity
by Zhou, Feifan
Cancer letters, 2015, Vol.359 (2), p.169-177
16.
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
by Ji, Ning Ning
Cancer letters, 2018-10-10, Vol.440-441, p.82-93
17.
SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
by Li, Xuqi
Cancer letters, 2012, Vol.322 (2), p.169-176
18.
Targeting Autophagy in Cancer Stem Cells as an Anticancer Therapy
by Lei, Yuanyuan
Cancer letters, 2017, Vol.393, p.33-39
19.
Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma
by Chang, Lei
Cancer letters, 2016, Vol.383 (2), p.183-194
20.
A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma
by Wang, Qixue
Cancer letters, 2016, Vol.373 (2), p.251-259
